# OnCo record firefly-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/firefly-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "firefly-bio" ;
  schema:name "Firefly Bio"@en ;
  schema:description "Firefly Bio attaches protein-destroying molecules to antibodies so they are delivered only into cancer cells, a new twist on antibody-drug conjugates. Johnson & Johnson bought the company for about 1 billion dollars in 2026."@en ;
  schema:url <https://onco.cc/companies/firefly-bio/>, <https://fireflybiologics.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://fireflybiologics.com/>, <https://fireflybiologics.com/press-release-firefly-bio-debuts-with-94-million-series-a-financing/>, <https://www.biopharmadive.com/news/jnj-firefly-acquisition-deal-cancer-degrader-antibody-conjugate/822223/> ;
  schema:addressCountry "US" ;
  onco:related <https://onco.cc/collections/src-biopharma-dive/> ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/degrader-antibody-conjugate/>, <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/protac-degrader/> .